However, IL6 blockade can “heat up” the TME and shift a “cold” TME to a “hot” one by fine-tuning the immune system towards a more anti-tumor phenotype, thereby enhancing the effectiveness of targeted immunotherapies [11,43]. The gene discussed is IL6; the disease is neoplasm.